triethylenemelamine has been researched along with Chronic Pain in 1 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konno, SI | 1 |
| Alev, L | 1 |
| Oda, N | 1 |
| Ochiai, T | 1 |
| Enomoto, H | 1 |
1 trial available for triethylenemelamine and Chronic Pain
| Article | Year |
|---|---|
An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
Topics: Adult; Aged; Analgesics; Chronic Pain; Constipation; Duloxetine Hydrochloride; Female; Humans; Japan | 2019 |